Wellmarker Bio enters clinical trial collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA Ruchika Sharma9 Feb 2023 2:15 PM ISTWM-A1-3389 is a novel therapeutic antibody targeting a new immune checkpoint protein discovered by Wellmarker Bio and has demonstrated efficacy across...
Preoperative anemia may increase risk of DVT formation before TJA Dr.Niharika Harsha B31 Jan 2023 9:45 AM ISTChina: Researchers from China found that preoperative anemia screening is necessary to identify preoperative deep vein thrombosis and perioperative...
CPAP novel non pharmacologic option for managing supine hypertension in Autonomic failure Dr.Niharika Harsha B30 Jan 2023 11:30 AM ISTA new study found that continuous positive airway pressure (CPAP) can be used as a novel nonpharmacologic approach for the management of supine...
Dr Reddy's labs completes clinical studies of Rituximab biosimilar for filing in US, Europe Ruchika Sharma20 Jan 2023 3:30 PM ISTWith the successful completion of these clinical studies, Dr. Reddy’s is now preparing to file Biologics License Application (BLA) / Marketing...
Sun Pharma's proposal to amend CT protocol for pimavanserin gets CDSCO Panel nod Dr. Divya Colin2 Jan 2023 6:00 PM ISTNew Delhi: Approving Sun Pharma's proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the...
Delhi HC directs centre to release over Rs 5 Cr to fund clinical trials for rare diseases Kajal Rajput1 Jan 2023 3:15 PM ISTThe petitioners, who are suffering from several rare diseases including Duchenne Muscular Dystrophy (DMD) and Mucopolysaccharidosis II or MPS II...
CDSCO Panel grants Pfizer's protocol amendment proposal for Tofacitinib Dr. Divya Colin25 Dec 2022 4:42 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
BioNTech begins clinical trial of mRNA-based malaria vaccine candidate Ruchika Sharma25 Dec 2022 12:15 PM ISTThe company said it will initially evaluate different antigens of the parasite that causes malaria over the coming months to help select the...
Submit Phase IV CT protocol: CDSCO Panel tells Roche over Anti-Cancer drug Pralsetinib Dr. Divya Colin16 Dec 2022 6:00 PM ISTNew Delhi: Reiterating the earlier recommendation regarding the condition of conduct a Phase IV clinical trial of anti-neoplastic drug Pralsetinib,...
Medical Bulletin 13/December/2022 Isra Zaman13 Dec 2022 1:03 PM ISTHere are the top medical news for the day:Extreme temperatures linked to cardiovascular deathsAmong the cardiovascular diseases examined in a recent...
AHA guidelines on management of acute coronary syndrome (ACS) in the older adult population Isra Zaman13 Dec 2022 9:45 AM ISTThe new statement, "Management of acute coronary syndrome (ACS) in the older adult population," highlights recent evidence to help clinicians better...
73 percent of patients in two clinical trials exhibit success in experimental cancer therapy Isra Zaman12 Dec 2022 9:45 AM ISTNearly all patients with myeloma who receive standard therapies continually relapse. Patients who relapse or become resistant to all approved...
